Rare Cancers – more common than you think
More than 4.3 million people in the European Union are affected by rare cancers. Despite the rarity of each of the 198 rare cancers, they represent in total about 22% of all cancer cases, including all cancers in children, diagnosed in the EU28 each year.
Rare Cancers Europe (RCE) is a multi-stakeholder initiative dedicated to putting rare cancers firmly on the European policy agenda and to implementing 39 political and stakeholder recommendations.
14 Aug 2015
RCE Patient Advocates course: meeting resources
University of Milan, 20 July 2015Starting from the Rare Cancers Europe consensus position paper on the methodology of clinical studies in rare cancers,...
01 Aug 2015
ESMO E-Learning: Multidisciplinary Treatment for Glioblastoma
Providing an update on key diagnostic, clinical, molecular, prognostic and predictive characteristics in patients with newly diagnosed and recurrent...
26 Jun 2015
RCE Patient Advocates course on the Methodology of clinical studies in rare cancers
University of Milan, 20 July 2015The meeting is addressed to around 100 European Patient Advocates with a strong interest in rare cancers and acting...